Moderna fends off Alnylam US patent lawsuit over COVID shots, for now
Alnylam Pharmaceuticals admitted defeat, for now, in a lawsuit in Delaware federal court that accused Moderna's blockbuster ...
Moderna under fire after children offered cash to test Covid vaccine
Moderna has been rebuked by regulators after offering children cash to test the Covid vaccine ...
Moderna Inc. stock underperforms Friday when compared to competitors
Shares of Moderna Inc. MRNA slid 1.42% to $60.20 Friday, on what proved to be an all-around great trading session for the ...
Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs
Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...
CNET on MSN1d
Novavax Is Here for the COVID Fight: What to Know About the Vaccine
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine
Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined.
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...
Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...
Jim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...
Abbas Hussain Joins Moderna’s Board of Directors
Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of Vifor Pharma ...
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, ...
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies have entered into a joint agreement regarding the co-promotion of ...